Clinical Trial Details

EORTC-2013-BTG

Back to Clinical Trials Database

Observational study for assessing treatment and outcome of patients with primary brain tumours diagnosed according to cIMPACT-NOW recommendations and the 2021 WHO classification

Study documentation

Trial Status Recruiting
Dates Date of activation: 21-Mar-2023
Data management at EORTC Yes
Design Cohort
Not randomized / N.A.
Targeted Sample size EORTC Groups: 6000 - All Groups: 6000
Treatment None
Study Staff Michael Weller (Study Coordinator) , UniversitaetsSpital Zurich - Neurology Clinic, Zurich
Jose Casas (TR Scientist) , EORTC Headquarters, Brussels
Corinne Daumer (Project Manager) , EORTC Headquarters, Brussels
Beatrice Fournier (Clinical Scientist) , EORTC Headquarters, Brussels
Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Lucia Gonzalez (Clinical Operations Manager) , EORTC Headquarters, Brussels
Thierry Gorlia (Statistician) , EORTC Headquarters, Brussels
Sven Janssen (Data Manager) , EORTC Headquarters, Brussels
Matthias Preusser (Study Co-Coordinator) , Universitaetsklinikum Wien - AKH unikliniken, Vienna
Caroline Quoilin (Clinical Scientist) , EORTC Headquarters, Brussels
Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Maarten Spruyt (Imaging DM) , EORTC Headquarters, Brussels
Maarten Spruyt (Data Manager) , EORTC Headquarters, Brussels
Eliza Starczewska (Junior RAM) , EORTC Headquarters, Brussels
Eliza Starczewska (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Hans-Georg Wirsching (Y-ECI Coordinator) , UniversitaetsSpital Zurich - Neurology Clinic, Zurich
Type of cancer Brain
Participating groups EORTC Brain Tumor Group
Recruiting centers A.O Landeskrankenhaus - Innsbruck Universitaetsklinik (Innsbruck, Austria)
APHP Sorbonne Univ - Hopital la Pitie-Salpetriere (PARIS, France)
AZ Delta - Campus Rumbeke (Roeselare, Belgium)
C.H.U. Sart-Tilman (Liege, Belgium)
CHU Lyon - Hopital neurologique Pierre Wertheimer (BRON CEDEX, France)
Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland)
Centro Hospitalar Universitario Lisboa Norte - Hospital Sta. Maria (Lisboa, Portugal)
Diagnostic & Therapeutic Center of Athens Hygeia Hospital S.A. (Athens, Greece)
Erasmus MC (Rotterdam, Netherlands)
Hopital de La Timone (APHM) (MARSEILLE, France)
Hospital Clinic de Barcelona (Barcelona, Spain)
ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain)
ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
IRCCS - Istituto Neurologico Carlo Besta (Milano, Italy)
IRCCS--Ospedale Bellaria-Bologna (Bologna, Italy)
Instituto Portugues de Oncologia de Lisboa Francisco Gentil – EPE (Lisboa, Portugal)
Leiden University Medical Centre (Leiden, Netherlands)
Newcastle Hospitals NHS Trust - Freeman Hospital, Northern Centre For Cancer Care (Newcastle upon Tyne, United Kingdom)
Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom)
Onze Lieve Vrouw Ziekenhuis (Aalst, Belgium)
Oslo University Hospital - Radiumhospitalet (Oslo, Norway)
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands)
Univ. of Florence -Azienda Ospedaliero-Universitaria Careggi (Firenze, Italy)
UniversitaetsSpital Zurich - Neurology Clinic (Zurich, Switzerland)
UniversitaetsSpital Zurich - Neurology Clinic (Zurich, Switzerland)
Universitaetsklinikum Regensburg (Regensburg, Germany)
Universitaetsklinikum Wien - AKH unikliniken (Vienna, Austria)
Universitair Ziekenhuis Brussel (Brussels, Belgium)
University Hospital Frankfurt -Senckenberg Institute of Neurooncology (Frankfurt am Main, Germany)
Centers to be activated AUSL Bologna - Ospedale Bellaria (Bologna, Italy)
Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Giovanni - Dipartimento Neuroscienze (Torino, Italy)
Azienda ospedaliero Univ Policlinico Umberto I (Roma, Italy)
Hospital De La Santa Creu I Sant Pau (Barcelona, Spain)
IRCCS - Istituto Oncologico Veneto (Padova, Italy)
IRCCS Ospedale San Raffaele (Milano, Italy)
IRCCS-Regina Elena National Cancer Center (Roma, Italy)
Institut Jules Bordet (Anderlecht, Belgium)
Institut de Cancerologie de l’Ouest (ICO) - Saint Herblain (Saint Herblain CEDEX, France)
NHS Lothian - The Royal Infirmary Of Edinburgh (Edinburgh, United Kingdom)
UMC-Academisch Ziekenhuis Utrecht (Utrecht, Netherlands)
Univ. Knappschaft Krankenhaus Bochum (Bochum-Langendreer, Germany)
Universitaetsklinikum - Essen (Essen, Germany)
Universitaetsklinikum Bonn (Bonn, Germany)
Universitaetsklinikum Jena (Jena, Germany)
Universitaetsklinikum Koeln (Koeln, Germany)
Universitaetsklinikum Leipzig-Klinik fuer Strahlentherapie und Radioonkologie (Leipzig, Germany)
University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre (Bristol, United Kingdom)
Protocol summary http://clinicaltrials.gov/study/NCT05259605
NCT number NCT05259605
Financial Support EORTC-BTG